US Food and Drug Administration Issues New Biosimilars Action Plan
27 Nov 2018
The US Food and Drug Administration issued a new Biosimilars Action Plan in July 2018 (“Plan”). The Plan’s main goals are to promote innovation, access to medicine, competition, introduce key actions (including establishing a new Office of Therapeutic Biologics […]